IVX 20.0% 0.4¢ invion limited

Anti-Cancer Immune Response - PhotosoftTM technology

  1. 5,991 Posts.
    lightbulb Created with Sketch. 100
    Hi Guys,

    Thought IVX needs a positive thread and an update, so we are looking at Human trials this year. Could be worth dollar cost averaging at these prices.

    About Photodynamic Therapy (PDT)Invion is developing PhotosoftTM technology as a novel next generation Photodynamic Therapy (PDT). PDT uses non-toxic photosensitisers and light to selectively kill cancer cells and promote an anti-cancer immune response. Less invasive than surgery and with minimal side effects, PDT offers an alternative treatment option aimed at achieving complete tumour regression and long-lasting remission. .
    R&D activities during the quarter Invion is focused on the development of the Photosoft™ technology for the treatment of cancers and infectious diseases and atherosclerosis (AID). During the quarter, the Company continued to work with its research partners to lay the groundwork for clinical trials in at least two types of cancers – skin and anogenital. These trials are expected to commence before the end of this calendar year.

    www.inviongroup.com.

    GLA

    DYOR
    Last edited by cashngrab: 27/06/23
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(20.0%)
Mkt cap ! $25.69M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $5.78K 1.445M

Buyers (Bids)

No. Vol. Price($)
30 12797949 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 7472779 27
View Market Depth
Last trade - 14.20pm 28/06/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.